Treating hypertension. Are the right drugs given to the right patients?

M D Beaulieu1, L Dufresne, D LeBlanc

  • 1Family Medicine Clinic, Notre-Dame Hospital. maried.beaulieu@sympatico.ca

Insights

Physicians sometimes prescribe antihypertensive drugs inappropriately, despite following some Canadian Hypertension Society guidelines. Understanding prescribing behaviors can improve hypertension management through targeted education.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Appropriate prescription of antihypertensive medications is crucial for managing hypertension and preventing complications.
  • Physician prescribing patterns may not always align with established clinical guidelines.

Purpose of the Study:

  • To assess the appropriateness of antihypertensive drug prescribing by physicians.
  • To evaluate adherence to Canadian Hypertension Society recommendations.

Main Methods:

  • Retrospective cohort study of 183 patients at a family medicine teaching clinic.
  • Analysis of antihypertensive medication prescriptions in relation to patient demographics, hypertension characteristics, and comorbidities.

Main Results:

  • Diuretics were most common (45.9%), followed by ACE inhibitors (28.4%).
  • Prescribing patterns were not associated with patient age, sex, hypertension duration, or blood pressure readings.
  • Beta-blocker use was linked to prior myocardial infarction; ACE inhibitor use in diabetics was low (32%).

Conclusions:

  • Some antihypertensive prescriptions were deemed inappropriate.
  • Physicians demonstrated partial adherence to Canadian Hypertension Society guidelines.
  • Further understanding of prescribing behaviors is needed to enhance hypertension treatment through education.
Abstract

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.